Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Apr 14:36:30.
doi: 10.1186/1824-7288-36-30.

VNS in drug resistant epilepsy: preliminary report on a small group of patients

Emilio Franzoni  1 , Valentina Gentile, Maria Chiara Colonnelli, Daniela Brunetto, Ilaria Cecconi, Luisa Iero, Filomena C Moscano, Duccio M Cordelli, Valentina Marchiani
Affiliations
Comparative Study

VNS in drug resistant epilepsy: preliminary report on a small group of patients

Emilio Franzoni et al. Ital J Pediatr. .

Abstract

Background: In 1997 Vagus Nerve Stimulation (VNS) received approval from the US Food and Drug Administration (FDA) as an adjunctive therapy in the treatment of medically intractable partial epilepsy in people aged 12 years and older who are ineligible for resective epilepsy surgery. Although the exact mechanisms of action are unknown, the use of VNS with children has increased, including those younger than 12 years of age, or those with generalized epilepsy.

Methods: We describe the outcome for the first group of nine patients, aged 8-28 years, who had pharmaco-resistant epilepsy and were treated with VNS. During the follow up, we gradually and slowly increased the parameters of the stimulation in order to assess the efficacy of VNS even at parameters which would usually be considered "non-therapeutic", along with possible side effects and changes in quality of life.

Results: At the last follow, up 1 patient was "seizures free", 3 were "very good responders", 3 were "good responders" and 2 were "non responders". We obtained an initial seizure reduction with low stimulation parameters, the highest current reached being 2.00 mA. This observation supports the possibility that, for younger patients, lower stimulation intensities than those commonly used in clinical practice for adults can be therapeutic. We also wanted to underline the reduction in seizure frequency (approximately 91.7%) and the reduction in seizure duration (> 50%) in the patients affected by drug-resistant absence epilepsy. Adverse effects were mild, tolerable and, in most of cases, easily resolved by adjusting the stimulation parameters. Hoarseness of voice was the most frequent side effect. The improvements in the quality of life are relevant and seem to be independent of the VNS effect in controlling seizures.

Conclusions: Our small experience seems to confirm the efficacy and safety of VNS in drug resistant partial and generalized epilepsy in developing age groups.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Improvement in Quality of Life (QOL) in our patients.
Figure 2
Figure 2
EEG of a patient before VNS implantation.
Figure 3
Figure 3
EEG of a patient after VNS implantation.
See this image and copyright information in PMC

References

    1. Blount JP, Tubbs RS, Kankirawatana P, Kiel S, Knowlton R, Grabb PA, Bebin M. Vagus Nerve Stimulation in Children Less than 5 years old. Childs Nerv Syst. 2006;22:1167–9. doi: 10.1007/s00381-006-0104-9. - DOI - PubMed
    1. Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R. Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev. 2008;31:291–297. doi: 10.1007/s10143-008-0134-8. - DOI - PubMed
    1. Rychlicki F, Zamponi N, Trignani R, Ricciuti RA, Iacoangeli M, Scerrati M. Vagus nerve stimulation: Clinical experience in drug-resistant pediatric epileptic patients. Seizure. 2006;15:483–90. doi: 10.1016/j.seizure.2006.06.001. - DOI - PubMed
    1. Aldenkamp AP, Veerdonk SH Van de, Majoie HJ, Berfelo MW, Evers SM, Kessels AG, Renier WO, Wilmink J. Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with Lennox-Gastaut Syndrome in an open clinical and non randomized study. Epilepsy Behav. 2001;2:343–50. doi: 10.1006/ebeh.2001.0218. - DOI - PubMed
    1. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006;15:491–503. doi: 10.1016/j.seizure.2006.06.002. - DOI - PubMed

Publication types